Mycobacterium Infections, Nontuberculous: Clinical Trials

170 trials for Mycobacterium Infections, Nontuberculous, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

103 completed, 20 recruiting, 17 unknown, 12 terminated. 52 Phase 2, 36 Not applicable, 23 Phase 1, 19 Phase 3, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 252Completed 29, Recruiting 7, Terminated 6, Unknown 3, Enrolling by invitation 2, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1
Not applicable36Completed 25, Recruiting 5, Not yet recruiting 2, Unknown 2, Active not recruiting 1, Terminated 1
Phase 123Completed 15, Terminated 2, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 319Completed 14, Recruiting 2, Terminated 2, Unknown 1
Phase 49Completed 6, Recruiting 2, Unknown 1

Follow Mycobacterium Infections, Nontuberculous: new trials by email Literature Review of Mycobacterium Infections, Nontuberculous trials Research Report on Mycobacterium Infections, Nontuberculous

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
Telacebec in Adults With Multibacillary Leprosy (TEBULA Leprosy Trial)
Telacebec 300 mg, Telacebec 600 mg, Telacebec + Rifampicine - Leprosy, Multibacillary
Phase 2Not yet recruitingFondation Raoul Follereau1202026-12-012026-11-05
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
Anifrolumab + APFS - Systemic Lupus Erythematosus
Phase 2RecruitingAstraZeneca242026-08-312026-10-28
Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
DP-QB-MYA-002 - Mycobacterium Abscessus Infection, Bacteriophage Therapy
Phase 1Not yet recruitingAlberta Health services12026-07-022026-02-24
Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers
A mobile app with AI functionality for diagnosing skin-related NTDs - Skin and Connective Tissue Diseases, Neglected Tropical Diseases
Not applicableNot yet recruitingKenya Medical Research Institute24202026-05-012026-04-02
Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Hansen's Disease in Costa Rica (2018-2025)
Leprosy, Hansen's Disease
Not yet recruitingCaja Costarricense de Seguro Social1302026-05-012026-03-09
Safety, Immunogenicity, and Efficacy of Therapeutic Mycobacterium Bovis BCG (BOOST)
Mycobacterium bovis Bacillus Calmette Guerin (BCG) vaccine, preservative-free saline - Mycobacterium Avium-intracellulare Infection, Mycobacterium Infections, Nontuberculous
Phase 2RecruitingUniversity of Virginia482026-04-272026-05-27
Epetraborole in Patients With Mycobacterium Abscessus Lung Disease
Epetraborole, Placebo - Mycobacterium Abscessus Infection
Phase 2RecruitingKevin Winthrop842026-03-302026-05-06
Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households
Multi-modal NTM diagnostic including PCR, WGS, culture - Cystic Fibrosis (CF), Mucoviscidosis
RecruitingResearch Center Borstel1202026-02-162026-08-19
Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection
Mycobacteriophage Muddy_HRMN0052, Amikacin Injection, Clofazimine - Non-Tuberculous Mycobacterial (NTM) Pneumonia, Mycobacterium Abscessus Infection
Phase 1Enrolling by invitationVancouver Coastal Health12026-01-112026-06-03
Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus Disease
Contezolid, linezolid - Monotherapy, Mycobacterium Abscessus Infection
Phase 2Enrolling by invitationBeijing Chest Hospital242026-01-012026-01-28
Clinical Characteristics and Immune Escape Mechanism of Nontuberculous Mycobacterial Lung Disease in South China
Prospective Biospecimen Sub-cohort - Nontuberculous Mycobacterial Lung Disease, Mycobacterium Avium Complex (MAC)
Not yet recruitingEighth Affiliated Hospital, Sun Yat-sen University15002026-01-012026-01-30
Accuracy of the Polymerase Chain Reaction of Ulnar Perineural Subcutaneous Aspirate Guided by Ultrasound for the Diagnosis and Monitoring of Leprosy Cure
Ultrasound-Guided Ulnar Perineural Subcutaneous Aspirate - Leprosy, Leprosy Neuropathy
Not applicableRecruitingUniversity of Brasilia1082026-01-012026-04-07
Integrating Mental Health Into Neglected Tropical Disease Care in Ghana
WHO Essential Care package for mental health and NTDs - Leprosy, Lymphatic Filariases
Not applicableNot yet recruitingLiverpool School of Tropical Medicine2002025-11-012025-11-25
Hypertonic Saline Inhalation for Nontuberculous Mycobacterial Lung Disease
Nebulized 3% Hypertonic Saline, Nebulized Normal Saline - Nontuberculous Mycobacterial Lung Disease, Bronchiectasis
Not applicableRecruitingTaipei Veterans General Hospital, Taiwan2622025-10-032026-06-15
SARS-CoV-2 Specific Monoclonal Antibody for Post-COVID-19 Conditions (Long COVID)
Placebo, Sipavibart - Post-COVID / Long-COVID
Phase 2RecruitingNancy Klimas1002025-07-282026-09-29
Leprosy Active Searching Trial in Brazil
Implementing active-case finding strategies - Leprosy
Not applicableCompletedHospital Alemão Oswaldo Cruz3232025-06-012026-08-04
Auricular Electroacupuncture and Auricular Acupuncture With Health Education for Pain in Leprosy
Auricular Electroacupuncture, Auricular Acupuncture, Health Education - Leprosy
Not applicableCompletedUniversidade Federal de Pernambuco162025-04-012026-10-07
Trauma-Informed Motivational Interviewing in Rural Dwelling Samples
Trauma-Informed Motivational Interviewing - Discrimination, Perceived
Not applicableRecruitingAlexandria University702025-03-012025-04-23
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease
Sitafloxacin - Fluoroquinolone, Mycobacterium
Phase 2Enrolling by invitationBeijing Chest Hospital122025-01-282025-02-05

Showing 20 of 170. Sign in to see all of them.

Narrower conditions

Mycobacterium avium-intracellulare Infection (66)  ·  Leprosy (52)  ·  HIV Infections (33)  ·  Acquired Immunodeficiency Syndrome (27)  ·  AIDS-Related Opportunistic Infections (15)  ·  Mycobacterium Infections (15)  ·  Buruli Ulcer (12)  ·  Cystic Fibrosis (9)  ·  Leprosy, Multibacillary (6)  ·  Lung Diseases (6)  ·  Tuberculosis (6)  ·  Communicable Diseases (4)  ·  Infections (4)  ·  Leprosy, Lepromatous (4)

Broader conditions

Actinomycetales Infections (169)  ·  Bacterial Infections and Mycoses (169)  ·  Gram-Positive Bacterial Infections (168)  ·  Bacterial Infections (167)  ·  Infections (166)  ·  Mycobacterium Infections (155)  ·  Immune System Diseases (39)  ·  Virus Diseases (37)  ·  RNA Virus Infections (36)  ·  Urogenital Diseases (36)  ·  Blood-Borne Infections (34)  ·  Communicable Diseases (34)  ·  Genital Diseases (34)  ·  Immunologic Deficiency Syndromes (34)

Interventions

Azithromycin (19)  ·  Rifabutin (16)  ·  Clarithromycin (15)  ·  Ethambutol (15)  ·  Clofazimine (11)  ·  Rifampin (10)  ·  bedaquiline (5)  ·  Amikacin (4)  ·  Cyclosporine (4)  ·  Dapsone (4)  ·  Linezolid (4)  ·  Prednisolone (4)  ·  Adrenal Cortex Hormones (3)  ·  Doxycycline (3)  ·  Inhalation (3)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (23)  ·  London School of Hygiene and Tropical Medicine (6)  ·  Pfizer (6)  ·  Pharmacia (6)  ·  Insmed Incorporated (4)  ·  Institute of Tropical Medicine, Belgium (4)  ·  Seoul National University Hospital (4)  ·  Beijing Chest Hospital (3)  ·  Kevin Winthrop (3)  ·  National Jewish Health (3)  ·  The University of Texas Health Science Center at Tyler (3)  ·  University Medical Center Groningen (3)  ·  Aswan University (2)  ·  Beyond Air Inc. (2)  ·  Colorado State University (2)

Countries

United States (72)  ·  Brazil (12)  ·  Australia (10)  ·  South Korea (9)  ·  Canada (8)  ·  Taiwan (8)  ·  Ethiopia (6)  ·  United Kingdom (6)  ·  China (5)  ·  Indonesia (5)  ·  Israel (5)  ·  Japan (5)  ·  Bangladesh (4)  ·  Benin (4)  ·  Comoros (4)

Top investigators

Kevin L Winthrop, MD, MPH (3)  ·  Benson CA (2)  ·  Diana NJ Lockwood, MBChB (2)  ·  Jerry Nick, MD (2)  ·  Judith Currier (2)  ·  Wei-Hung Hsu (2)  ·  Younoussa Assoumani (2)  ·  Abdallah Mahmoud Abdallah, Professor (1)  ·  Abdul H Salim, MBBS (1)  ·  Alexander Mischnik, Prof. Dr. med. (1)  ·  Alexander Y Debrah, PhD (1)  ·  Allen McCutchan (1)  ·  Amy Manley (1)

Results publications

PMID 24874401, PMID 27097163, PMID 30216086, PMID 33595792, PMID 35850123, PMID 10526739, PMID 106465, PMID 11202234, PMID 15079177, PMID 15302746, PMID 16012514, PMID 16131307, PMID 16248209, PMID 19571027, PMID 20137805, PMID 20698989, PMID 21293986, PMID 21445325, PMID 21508125, PMID 21756569, PMID 22156855, PMID 22312016, PMID 22826694, PMID 22846185, PMID 23344397, PMID 24077845, PMID 25097193, PMID 25389921, PMID 25530971, PMID 25771459, PMID 25884704, PMID 26214350, PMID 26562499, PMID 27457707, PMID 27748623, PMID 28061905, PMID 28222139, PMID 28704363, PMID 28841158, PMID 29605498, PMID 29635431, PMID 29867930, PMID 29908231, PMID 30102705, PMID 30151192, PMID 30837992, PMID 31000680, PMID 31148869, PMID 31389998, PMID 31449522

NIH funding

2014 (1), 2017 (1), 2023 (1), 2025 (1), 5UL1RR024982-02 (1), K23AI159145 (1)